← FDA DRUG APPROVALS

FDA ANDA · ANDA203773

DEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: AM REGENT

APPLICATION
ANDA203773
TYPE
ANDA
ORIGINAL APPROVAL
2017-05-12
LATEST ACTION
2017-05-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEXMEDETOMIDINE HYDROCHLORIDEDiscontinued
DEXMEDETOMIDINE HYDROCHLORIDE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) · INJECTABLE · INJECTION

Approval history

2017-05-12UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →